De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.

Costa F, Vizzari G, Zecchino S, Galli M, Montalto C, Carciotto G, Quadri G, Vergallo R, Castriota F, Soraci E, Magliarditi A, Giudice SL, Iuvara G, Munafò A, Giannino F, Pallante F, Franzino M, Teresi L, Piccolo R, Varbella F, Musumeci G, Di Bella G, Ortega-Paz L, Angiolillo DJ, Micari A

Open source

DOI: 10.1016/j.carrev.2026.07.022
Published: 2026 Aug 4
Container: Cardiovascular revascularization medicine : including molecular interventions
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.carrev.2026.07.022,
  title = {De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.},
  author = {Costa F and Vizzari G and Zecchino S and Galli M and Montalto C and Carciotto G and Quadri G and Vergallo R and Castriota F and Soraci E and Magliarditi A and Giudice SL and Iuvara G and Munafò A and Giannino F and Pallante F and Franzino M and Teresi L and Piccolo R and Varbella F and Musumeci G and Di Bella G and Ortega-Paz L and Angiolillo DJ and Micari A},
  year = {2026},
  journal = {Cardiovascular revascularization medicine : including molecular interventions},
  doi = {10.1016/j.carrev.2026.07.022},
  url = {https://doi.org/10.1016/j.carrev.2026.07.022}
}

RIS

TY  - JOUR
TI  - De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.
AU  - Costa F
AU  - Vizzari G
AU  - Zecchino S
AU  - Galli M
AU  - Montalto C
AU  - Carciotto G
AU  - Quadri G
AU  - Vergallo R
AU  - Castriota F
AU  - Soraci E
AU  - Magliarditi A
AU  - Giudice SL
AU  - Iuvara G
AU  - Munafò A
AU  - Giannino F
AU  - Pallante F
AU  - Franzino M
AU  - Teresi L
AU  - Piccolo R
AU  - Varbella F
AU  - Musumeci G
AU  - Di Bella G
AU  - Ortega-Paz L
AU  - Angiolillo DJ
AU  - Micari A
PY  - 2026
JO  - Cardiovascular revascularization medicine : including molecular interventions
DO  - 10.1016/j.carrev.2026.07.022
UR  - https://doi.org/10.1016/j.carrev.2026.07.022
ER  -

APA

F, C., G, V., S, Z., M, G., C, M., G, C., G, Q., R, V., F, C., E, S., A, M., SL, G., G, I., A, M., F, G., F, P., M, F., L, T., R, P., F, V., G, M., G, D. B., L, O., DJ, A., & A, M. (2026). De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.. Cardiovascular revascularization medicine : including molecular interventions. https://doi.org/10.1016/j.carrev.2026.07.022

Source records

pubmed · retrieved 2026-09-25T22:44:57.402Z
europe-pmc · retrieved 2026-09-25T22:44:57.412Z